蒋伟被证监会处罚，系这家百亿巨头实控人之一，还是富豪榜常客！公司回应：涉及事项与公司无关！

Core Viewpoint - The recent penalty imposed on Jiang Wei is personal and unrelated to Haohai Biological Technology Co., Ltd, which he founded but has not actively managed for years [1][4]. Group 1: Company Background - Haohai Biological Technology is a high-tech biopharmaceutical company focused on the research, production, and sales of medical biomaterials, notably hyaluronic acid [4]. - The company was established from Haohai Limited, which Jiang Wei founded, and entered the hyaluronic acid sector in May 2007 [4]. - Hou Yongtai has been the chairman since 2009, while Jiang Wei has remained in the background without any official role in the company [4]. Group 2: Financial Performance - Since its listing in 2019, Haohai Biological has shown a general upward trend in performance, with revenue increasing from 1.6 billion yuan in 2019 to an expected 2.7 billion yuan in 2024 [4]. - The net profit attributable to shareholders has consistently exceeded 200 million yuan, reaching a projected 420 million yuan in 2024, marking a record high since its IPO [4]. - The company has distributed a total of 890 million yuan in cash dividends since its A-share listing, with Jiang Wei personally receiving approximately 254 million yuan from these dividends [4]. Group 3: Shareholding Structure - Jiang Wei and his wife collectively held a significant portion of Haohai Biological's shares, with their ownership percentage increasing from 41.18% to 45.82% over the years [4]. - This shareholding structure indicates that approximately 40% of the total dividends distributed, amounting to 890 million yuan, were allocated to Jiang Wei and his wife [4]. Group 4: Wealth Status - In 2020, Jiang Wei and his wife first appeared on the Hurun Global Rich List with a wealth of 7 billion yuan, maintaining a position on the list for five consecutive years [5]. - As of March 27, 2023, they were ranked 3206th on the Hurun Global Rich List with a wealth of 7.3 billion yuan [5]. - Despite the dividends, Jiang Wei has not benefited significantly from stock market fluctuations, with the company's market value dropping from 15.5 billion yuan at its IPO to 11.55 billion yuan as of September 16, 2023 [5].